Guangzhou Institute Of Respiratory Disease

This phase 2 trial is testing whether a combination of two drugs, lurbinectedin and serplulimab, can help keep extensive-stage small cell lung cancer from growing when used as maintenance therapy after initial chemo-immunotherapy. About 30 adults whose cancer has not worsened aft…

This study is testing antibody-drug conjugates (ADCs) on tiny lab-grown versions of lung cancer tumors called organoids. The goal is to understand how these drugs kill cancer cells and interact with the immune system. Researchers will study 10 people with HER2- or TROP2-positive …